NF-κB: an essential transcription factor in psoriasis

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Nuclear factor kappa B (NF-κB) is a critical transcription factor regulating inflammation, immunity, cell proliferation, and apoptosis.
• NF-κB plays a significant role in the pathogenesis of psoriasis, an inflammatory skin condition characterized by elevated active NF-κB levels.

Purpose of the Study:

• To explore the role of NF-κB in psoriasis pathogenesis.
• To investigate NF-κB as a therapeutic target for psoriasis and other inflammatory disorders.

Main Methods:

• Review of genomic studies linking psoriasis to NF-κB pathway mediators.
• Analysis of current and developing anti-psoriatic therapies targeting NF-κB.
• Discussion of potential strategies for safe and effective NF-κB inhibition.

Main Results:

• NF-κB is hypothesized to link altered keratinocyte and immune cell behavior in psoriasis.
• Existing therapies like TNF-α blockers and glucocorticoids reduce active NF-κB.
• Emerging biologics, such as IL-17 blockers, may also target the NF-κB pathway.

Conclusions:

• Targeting NF-κB signaling presents a novel therapeutic avenue for psoriasis and chronic inflammatory diseases.
• Chronic NF-κB inhibition carries risks, including potential immunodeficiencies.
• Therapeutic strategies must balance efficacy with safety, possibly through localized therapy, selective inhibition, or dose/duration adjustments.